Urso 250 (Ursodiol) - Summary

URSO 250 SUMMARY

URSO 250™ is a bile acid available as 250 mg film-coated tablets for oral administration.

URSO 250™ (ursodiol) tablets are indicated for the treatment of patients with primary biliary cirrhosis.

URSO 250 NEWS HIGHLIGHTS

Media Articles Related to Urso 250 (Ursodiol)

Primary Biliary Cirrhosis
Source: MedicineNet ursodiol Specialty [2005.09.17]

more>>

Published Studies Related to Urso 250 (Ursodiol)

Clinical Trial: Randomized controlled trial of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol. [2008.07.09]

Ursodeoxycholic acid treatment in preterm infants: a pilot study for the prevention of cholestasis associated with total parenteral nutrition. [2008.02]

Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid. [2007.06.27]

Ursodeoxycholic acid improves muscle contractility and inflammation in symptomatic gallbladders with cholesterol gallstones. [2007.06]

Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis. [2006.12]

more>>

Clinical Trials Related to Urso 250 (Ursodiol)

Trial of High-Dose Urso in Primary Sclerosing Cholangitis [Completed]

Ursodiol in Huntington's Disease [Recruiting]

Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) Patients [Completed]

Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C [Completed]

Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic Steatohepatitis [Recruiting]

more>>